Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

NCT01923545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy Induced Neutropenia

Interventions

DRUG: PEG-G-CSF
DRUG: G-CSF

Sponsor

Dong-A ST Co., Ltd.